'King Of Biotech' Settles Stock Manipulation Case For $1M

Law360, New York (August 23, 2013, 2:26 PM EDT) -- Biotech financier David A. Blech will pay $1.03 million in disgorgement for his role in a scheme to manipulate stock prices, according to a settlement with federal regulators approved by a New York federal judge Thursday.

Blech was convicted last year after admitting that he used a manipulative pattern of sales to prop up the price of shares in Pluristem Therapeutics Inc. and Intellect Neurosciences Inc. from 2005 to 2008 as he sought to sell off his stakes in the companies to pay debts.

Regulators said...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Securities and Exchange Commisison v. Blech et al


Case Number

1:12-cv-03703

Court

New York Southern

Nature of Suit

Securities/Commodities

Judge

Alison J. Nathan

Date Filed

May 9, 2012

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.